Narcolepsy Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Narcolepsy Drugs Market was valued at $2,680.06 million in 2020, and is projected to reach $6,667.80 million by 2028, registering a CAGR of 9% during the forecast period 2022 to 2028.

Narcolepsy is a chronic sleep disorder that affects the brain’s ability to regulate the sleep-wake cycle. It is characterized by overwhelming daytime sleepiness and sudden sleep attacks. People with narcolepsy often have difficulty staying awake for long periods of time and feel very sleepy throughout the day. Narcolepsy is a long-term neurological disorder characterized primarily by the classic 4 stages of irresistible sleep attacks, cataplexy (sudden bilateral loss of muscle tone), hypnotic hallucinations, and excessive daytime sleepiness with sleep paralysis. About 70% of individuals experience sudden loss of muscle strength, called cataplexy, which can be triggered by strong emotions. Less commonly, people may be unable to move or have vivid hallucinations when falling asleep or waking up. People with narcolepsy tend to sleep about the same amount of time a day as people who don’t, but they tend to have worse quality sleep.

Market Segments

By Disease Type

• Daytime Extreme Sleepiness
• Cataplexia
• Other Disease Type

By Therapeutics Type

• Central Nervous System Stimulants
• Tricyclic Antidepressants
• Sodium Oxybate
• Selective Serotonin Reuptake Inhibitor

Key Players

• Arena Pharmaceuticals, Inc.
• Bioprojet Company
• Graymark Healthcare, Inc.
• Hikma Pharmaceuticals PLC
• Jazz Pharmaceuticals plc
• Ligand Pharmaceuticals Incorporated
• Shionogi Inc.
• Takeda Pharmaceutical Company Limited
• Novartis International AG
• Teva Pharmaceutical Industries Limited

Scope of the Report

The research study analyzes the global Narcolepsy Drugs industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Narcolepsy Drugs Market Report

1. What was the Narcolepsy Drugs Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Narcolepsy Drugs Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Narcolepsy Drugs Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.